President Donald Trump announced the University of Miami has donated its original 1994 investigational new drug application for ibogaine to the federal government. This significant gift is intended to expedite the development of ibogaine as a treatment for serious mental illnesses, particularly among veterans. The 1994 application represents the foundational authorization that enabled early research into the psychedelic substance. Trump made this announcement via Truth Social, highlighting its importance for accelerating medical treatments in the U.S. This action directly supports an April executive order he signed, which aimed to speed up access to psychedelic therapies for mental health conditions. The president emphasized that this move is crucial for helping veterans and other Americans suffering from serious mental illness. He noted that the university's donation builds upon existing efforts, including research funding and inter-agency collaborations. Trump stressed the urgency of bringing potential new treatments to market quickly. He expressed hope that more organizations will join this critical initiative to support veterans. Health Secretary Robert F. Kennedy Jr. has been a vocal supporter, calling ibogaine a highly promising treatment for depression and PTSD.